Abstract
Though appropriate glucocorticoid substitution therapy should abolish both cortisol deficiency and adrenal androgen excess in patients with 21-hydroxylase deficiency (21-OHD), the longterm outcome is not always satisfactory. There are several reports on low adult height in both male and female patients, and impaired fertility has been reported in females with 21-OHD. There are only few reports on gonadal function of adult male patients with 21-OHD. In this study, we calculated the child rate of all the 29 diagnosed adult Finnish males with classical 21-OHD and compared it with the mean child rate of the whole Finnish male population with equal age distribution. Sixteen males with 21-OHD and their age-matched healthy controls were further examined in a cross-sectional study. Auxology and pituitary gonadal axis were examined in both patients and controls. Testicular ultrasonography of the patients was also performed. The mean child rate of the 29 males with 21-OHD was 0.07 which was significantly lower (p<0.001) than that in the Finnish male population of the same age (0.34). In the cross-sectional study, males with 21-OHD had serum testosterone, inhibin B, LH and FSH concentrations comparable to those of healthy controls and reference values. Serum DHEA-S concentrations were remarkably low, even in the undersubstituted males with 21-OHD (p<0.001, compared with the healthy controls). In the patient group, serum inhibin B concentration did not correlate with serum FSH concentration. Adrenal rest tumors of the testicles were found in two undersubstituted males with 21-OHD. In conclusion, our study suggests normal pituitary and gonadal function but reduced child rate in adult males with 21-OHD. This might be explained by suboptimal psychosocial adaptation to the chronic disease. However, the patients in this study were young and the final child rate may become essentially higher.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
New M.I. Steroid 21-hydroxylase deficiency (congenital adrenal hyperplasia). Am. J. Med. 1995, 98: 2S–8S.
Jääskeläinen J., Levo A., Voutilainen R., Partanen J. Population-wide evaluation of disease manifestation in relation to molecular genotype in steroid 21-hydroxylase (CYP21) deficiency: good correlation in a well defined population. J. Clin. Endocrinol. Metab. 1997, 82: 3293–3297.
Holmes Walker D.J., Conway G.S., Honour J.W., Rumsby G., Jacobs H.S. Menstrual disturbance and hypersecretion of progesterone in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin. Endocrinol. (Oxf.) 1995, 43: 291–296.
Helleday J., Siwers B., Ritzen E.M., Carlstrom K. Subnormal androgen and elevated progesterone levels in women treated for congenital virilizing 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 1993, 76: 933–936.
Mulaikal R.M., Migeon C.J., Rock J.A. Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N. Engl. J. Med. 1987, 316: 178–182.
Urban M.D., Lee P.A., Migeon C.J. Adult height and fertility in men with congenital virilizing adrenal hyperplasia. N. Engl. J. Med. 1987, 299: 1392–1396.
Walker B.R., Skoog S.J., Winslow B.H., Canning D.A., Tank E.S. Testis sparing surgery for steroid unresponsive testicular tumors of the adrenogenital syndrome. J. Urol. 1997, 157: 1460–1463.
Combes-Moukhovsky M.E., Kottler M.L., Valensi P., Boudou P., Sibony M., Attali J.R. Gonadal and adrenal catheterization during adrenal suppression and gonadal stimulation in a patient with bilateral testicular tumors and congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 1994, 79: 1390–1394.
Srikanth M.S., West B.R., Ishitani M., Isaacs H. Jr., Applebaum H., Costin G. Benign testicular tumors in children with congenital adrenal hyperplasia. J. Pediatr. Surg. 1992, 27: 639–641.
Willi U., Atares M., Prader A., Zachmann M. Testicular adrenal-like tissue (TALT) in congenital adrenal hyperplasia: detection by ultrasonography. Pediatr. Radiol. 1992, 21: 284–287.
Blumberg-Tick J., Boudou P., Nahoul K., Schaison G. Testicular tumors in congenital adrenal hyperplasia: steroid measurements from adrenal and spermatic veins. J. Clin. Endocrinol. Metab. 1991, 73: 1129–1133.
Vanzulli A., Del Maschio A., Paesano P., Braggion F., Livieri C., Angeli E. Testicular masses in association with adrenogenital syndrome: US findings. Radiology 1992, 183: 425–429.
Augarten A., Weissenberg R., Pariente C., Sack J. Reversible male infertility in late onset congenital adrenal hyperplasia. J. Endocrinol. Invest. 1991, 14: 237–240.
Cutfield R.G., Bateman J.M., Odell W.D. Infertility caused by bilateral testicular masses secondary to congenital adrenal hyperplasia (21-hydroxylase deficiency). Fertil. Steril. 1983, 40: 809–814.
Keely E.J., Matwijiw I., Thliveris J.A., Faiman C. Congenital adrenal hyperplasia with testicular tumors, aggression and gonadal failure. Urology 1993, 41: 346–349.
Helleday J., Bartfai A., Ritzen E.M., Forsman M. General intelligence and cognitive profile in women with congenital adrenal hyperplasia (CAH). Psychoneuroendocrinology 1994, 19: 343–356.
Federman D.D. Psychosexual adjustment in congenital adrenal hyperplasia. N. Engl. J. Med. 1987, 316: 209–210.
Population Structure 1995. Statistics Finland, Helsinki, 1996, p. 67.
Smith S. Free testosterone. In: Service Training and Continuing Education. American Association for Clinical Chemistry, Washington D.C., 1993, p. 59.
Jääskeläinen J., Voutilainen R. Bone mineral density in relation to glucocorticoid substitution therapy in adult patients with 21-hydroxylase deficiency. Clin. Endocrinol. 1996, 45: 707–713.
Jensen T.K., Andersson A.M., Hjollund N.H., Scheike T., Kolstad H., Giwercman A., Henriksen T.B., Ernst E., Bonde J.P., Olsen J., McNeilly A., Groome N.P., Skakkebaek N.E. Inhibin B as a serum marker of spermatogenesis: correlation to differences in sperm concentration and follicle-stimulating hormone levels. A study of 349 Danish men. J. Clin. Endocrinol. Metab. 1997, 1997: 4059–4063.
Sellers E.P., MacGillivray M.H. Blunted adrenarche in patients with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr. Res. 1995, 21: 537–544.
Rezvani I., Garibaldi L.R., Digeorge A.M., Artman H.G. Disproportionate suppression of dehydroepiandrosterone sulfate (DHEAS) in treated patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatr Res. 1983, 17: 131–134.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jääskeläinen, J., Kiekara, O., Hippeläinen, M. et al. Pituitary gonadal axis and child rate in males with classical 21-hydroxylase deficiency. J Endocrinol Invest 23, 23–27 (2000). https://doi.org/10.1007/BF03343671
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03343671